394 related articles for article (PubMed ID: 18708590)
1. Helminth 2-Cys peroxiredoxin drives Th2 responses through a mechanism involving alternatively activated macrophages.
Donnelly S; Stack CM; O'Neill SM; Sayed AA; Williams DL; Dalton JP
FASEB J; 2008 Nov; 22(11):4022-32. PubMed ID: 18708590
[TBL] [Abstract][Full Text] [Related]
2. Thioredoxin peroxidase secreted by Fasciola hepatica induces the alternative activation of macrophages.
Donnelly S; O'Neill SM; Sekiya M; Mulcahy G; Dalton JP
Infect Immun; 2005 Jan; 73(1):166-73. PubMed ID: 15618151
[TBL] [Abstract][Full Text] [Related]
3. Immunological interactions between 2 common pathogens, Th1-inducing protozoan Toxoplasma gondii and the Th2-inducing helminth Fasciola hepatica.
Miller CM; Smith NC; Ikin RJ; Boulter NR; Dalton JP; Donnelly S
PLoS One; 2009 May; 4(5):e5692. PubMed ID: 19478853
[TBL] [Abstract][Full Text] [Related]
4.
Jin QW; Zhang NZ; Li WH; Qin HT; Liu YJ; Ohiolei JA; Niu DY; Yan HB; Li L; Jia WZ; Song MX; Fu BQ
Front Immunol; 2020; 11():2015. PubMed ID: 33072069
[No Abstract] [Full Text] [Related]
5. Helminth infection protects mice from anaphylaxis via IL-10-producing B cells.
Mangan NE; Fallon RE; Smith P; van Rooijen N; McKenzie AN; Fallon PG
J Immunol; 2004 Nov; 173(10):6346-56. PubMed ID: 15528374
[TBL] [Abstract][Full Text] [Related]
6. Defined Intestinal Regions Are Drained by Specific Lymph Nodes That Mount Distinct Th1 and Th2 Responses Against
Mayer JU; Brown SL; MacDonald AS; Milling SW
Front Immunol; 2020; 11():592325. PubMed ID: 33193437
[TBL] [Abstract][Full Text] [Related]
7. T cell-derived IL-4/IL-13 protects mice against fatal Schistosoma mansoni infection independently of basophils.
Schwartz C; Oeser K; Prazeres da Costa C; Layland LE; Voehringer D
J Immunol; 2014 Oct; 193(7):3590-9. PubMed ID: 25172500
[TBL] [Abstract][Full Text] [Related]
8. The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils.
Driss V; El Nady M; Delbeke M; Rousseaux C; Dubuquoy C; Sarazin A; Gatault S; Dendooven A; Riveau G; Colombel JF; Desreumaux P; Dubuquoy L; Capron M
Mucosal Immunol; 2016 Mar; 9(2):322-35. PubMed ID: 26174763
[TBL] [Abstract][Full Text] [Related]
9. Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems.
Vicente B; López-Abán J; Rojas-Caraballo J; del Olmo E; Fernández-Soto P; Muro A
Parasit Vectors; 2016 Apr; 9():216. PubMed ID: 27090442
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of retinal dehydrogenase 2 in alternatively activated macrophages during retinoid-dependent type-2 immunity to helminth infection in mice.
Broadhurst MJ; Leung JM; Lim KC; Girgis NM; Gundra UM; Fallon PG; Premenko-Lanier M; McKerrow JH; McCune JM; Loke P
PLoS Pathog; 2012; 8(8):e1002883. PubMed ID: 22927819
[TBL] [Abstract][Full Text] [Related]
11. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.
Pemberton RM; Wilson RA
Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008
[TBL] [Abstract][Full Text] [Related]
12. Major secretory antigens of the helminth Fasciola hepatica activate a suppressive dendritic cell phenotype that attenuates Th17 cells but fails to activate Th2 immune responses.
Dowling DJ; Hamilton CM; Donnelly S; La Course J; Brophy PM; Dalton J; O'Neill SM
Infect Immun; 2010 Feb; 78(2):793-801. PubMed ID: 19917714
[TBL] [Abstract][Full Text] [Related]
13. Immunization with adult
El-Aswad BEW; Harba NM; Moharm IM; Mahmoud SF
J Helminthol; 2019 Jan; 94():e26. PubMed ID: 30702051
[TBL] [Abstract][Full Text] [Related]
14. The IL-21 receptor augments Th2 effector function and alternative macrophage activation.
Pesce J; Kaviratne M; Ramalingam TR; Thompson RW; Urban JF; Cheever AW; Young DA; Collins M; Grusby MJ; Wynn TA
J Clin Invest; 2006 Jul; 116(7):2044-55. PubMed ID: 16778988
[TBL] [Abstract][Full Text] [Related]
15. Cysteine peptidases as schistosomiasis vaccines with inbuilt adjuvanticity.
El Ridi R; Tallima H; Selim S; Donnelly S; Cotton S; Gonzales Santana B; Dalton JP
PLoS One; 2014; 9(1):e85401. PubMed ID: 24465551
[TBL] [Abstract][Full Text] [Related]
16. Schistosoma mansoni hemozoin modulates alternative activation of macrophages via specific suppression of Retnla expression and secretion.
Truscott M; Evans DA; Gunn M; Hoffmann KF
Infect Immun; 2013 Jan; 81(1):133-42. PubMed ID: 23090958
[TBL] [Abstract][Full Text] [Related]
17. In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.
Hernandez HJ; Wang Y; Stadecker MJ
J Immunol; 1997 May; 158(10):4832-7. PubMed ID: 9144498
[TBL] [Abstract][Full Text] [Related]
18. Schistosoma mansoni and alpha-galactosylceramide: prophylactic effect of Th1 Immune suppression in a mouse model of Graves' hyperthyroidism.
Nagayama Y; Watanabe K; Niwa M; McLachlan SM; Rapoport B
J Immunol; 2004 Aug; 173(3):2167-73. PubMed ID: 15265954
[TBL] [Abstract][Full Text] [Related]
19. The absence of MyD88 has no effect on the induction of alternatively activated macrophage during Fasciola hepatica infection.
Luo H; Huang W; Wang D; Wang H; Nie K
BMC Immunol; 2011 Nov; 12():63. PubMed ID: 22074389
[TBL] [Abstract][Full Text] [Related]
20. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
